Free Access
Vet. Res.
Volume 36, Number 2, March-April 2005
Page(s) 229 - 240
How to cite this article Vet. Res. (2005) 229-240
References of Vet. Res. 36 (2005) 229-240
  1. Akgul C., Turner P.C., White M.R., Edwards S.W., Functional analysis of the human MCL-1 gene, Cell. Mol. Life Sci. 57 (2000) 684-691 [CrossRef] [PubMed].
  2. Barkett M., Gilmore T.D., Control of apoptosis by Rel/NF-kappaB transcription factors, Oncogene 18 (1999) 6910-6924 [CrossRef] [PubMed].
  3. Borner C., The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions, Mol. Immunol. 39 (2003) 615-647 [CrossRef] [PubMed].
  4. Bortner C.D., Cidlowski J.A., Apoptotic volume decrease and the incredible shrinking cell, Cell Death Differ. 9 (2002) 1307-1310 [CrossRef] [PubMed].
  5. Boulanger D., Bureau F., Melotte D., Mainil J., Lekeux P., Increased nuclear factor kappaB activity in milk cells of mastitis-affected cows, J. Dairy Sci. 86 (2003) 1259-1267 [PubMed].
  6. Brach M.A., deVos S., Gruss H.J., Herrmann F., Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death, Blood 80 (1992) 2920-2924 [PubMed].
  7. Burlacu A., Regulation of apoptosis by Bcl-2 family proteins, J. Cell. Mol. Med. 7 (2003) 249-257 [PubMed].
  8. Chuang P.I., Yee E., Karsan A., Winn R.K., Harlan J.M., A1 is a constitutive and inducible Bcl-2 homologue in mature human neutrophils, Biochem. Biophys. Res. Commun. 19 (1998) 361-365 [CrossRef].
  9. Colotta F., Re F., Polentarutti N., Sozzani S., Mantovani A., Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products, Blood 80 (1992) 2012-2020 [PubMed].
  10. Daigle I., Simon H.U., Critical role for caspases 3 and 8 in neutrophil but not eosinophil apoptosis, Int. Arch. Allergy Immunol. 126 (2001) 147-156 [CrossRef] [PubMed].
  11. Denault J.B., Salvesen G.S., Caspases: keys in the ignition of cell death, Chem. Rev. 102 (2002) 4489-4500 [CrossRef] [PubMed].
  12. Grumont R.J., Rourke I.J., Gerondakis S., Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis, Genes Dev. 13 (1999) 400-411 [PubMed].
  13. Hotta K., Niwa M., Hara A., Ohno T., Wang X., Matsuno H., Kozawa O., Ito H., Kato K., Otsuka T., Matsui N., Uematsu T., The loss of susceptibility to apoptosis in exudated tissue neutrophils is associated with their nuclear factor-kappa B activation, Eur. J. Pharmacol. 433 (2001) 17-27 [CrossRef] [PubMed].
  14. Karin M., Lin A., NF-kappaB at the crossroads of life and death, Nat. Immunol. 3 (2002) 221-227 [CrossRef] [PubMed].
  15. Kobayashi S.D., Voyich J.M., DeLeo F.R., Regulation of the neutrophil-mediated inflammatory response to infection, Microbes Infect. 5 (2003) 1337-1344 [CrossRef] [PubMed].
  16. Kroll M., Arenzana-Seisdedos F., Bachelerie F., Thomas D., Friguet B., Conconi M., The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome, Chem. Biol. 6 (1999) 689-698 [CrossRef] [PubMed].
  17. Lee A., Whyte M.K., Haslett C., Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators, J. Leukoc. Biol. 54 (1993) 283-288 [PubMed].
  18. Lee D., Long S.A., Adams J.L., Chan G., Vaidya K.S., Francis T.A., Kikly K., Winkler J.D., Sung C.M., Debouck C., Richardson S., Levy M.A., DeWolf W.E. Jr., Keller P.M., Tomaszek T., Head M.S., Ryan M.D., Haltiwanger R.C., Liang P.H., Janson C.A., McDevitt P.J., Johanson K., Concha N.O., Chan W., Abdel-Meguid S.S., Badger A.M., Lark M.W., Nadeau D.P., Suva L.J., Gowen M., Nuttall M.E., Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality, J. Biol. Chem. 275 (2000) 16007-16014 [CrossRef] [PubMed].
  19. Lee D., Long S.A., Murray J.H., Adams J.L., Nuttall M.E., Nadeau D.P., Kikly K., Winkler J.D., Sung C.M., Ryan M.D., Levy M.A., Keller P.M., DeWolf W.E. Jr., Potent and selective nonpeptide inhibitors of caspases 3 and 7, J. Med. Chem. 44 (2001) 2015-2026 [CrossRef] [PubMed].
  20. Leuenroth S.J., Grutkoski P.S., Ayala A., Simms H.H., The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis, J. Leukoc. Biol. 68 (2000) 158-166 [PubMed].
  21. Liu Y., Zhang J., Zhao Z., Ling Y., Pro-apoptotic role of NF-kappaB pathway inhibition in lipopolysaccharide-stimulated polymorphonuclear neutrophils, Chin. Med. J. 116 (2003) 1257-1261 [PubMed].
  22. Liu Z.G., Hsu H., Goeddel D.V., Karin M., Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death, Cell 87 (1996) 565-576 [CrossRef] [PubMed].
  23. McDonald P.P., Bald A., Cassatella M.A., Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils, Blood 89 (1997) 3421-3433 [PubMed].
  24. McDonald P.P., Cassatella M.A., Activation of transcription factor NF-kappa B by phagocytic stimuli in human neutrophils, FEBS Lett. 412 (1997) 583-586 [CrossRef] [PubMed].
  25. Moore P.A., Ruben S.M., Rosen C.A., Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae, Mol. Cell. Biol. 13 (1993) 1666-1674 [PubMed].
  26. Moulding D.A., Quayle J.A., Hart C.A., Edwards S.W., Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival, Blood 92 (1998) 2495-2502 [PubMed].
  27. Moulding D.A., Akgul C., Derouet M., White M.R., Edwards S.W., BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis, J. Leukoc. Biol. 70 (2001) 783-792 [PubMed].
  28. Murray J., Barbara J.A., Dunkley S.A., Lopez A.F., Van O.X., Condliffe A.M., Dransfield I., Haslett C., Chilvers E.R., Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro, Blood 90 (1997) 2772-2783 [PubMed].
  29. Niwa M., Hara A., Kanamori Y., Hatakeyama D., Saio M., Takami T., Matsuno H., Kozawa O., Uematsu T., Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis, Eur. J. Pharmacol. 407 (2000) 211-219 [CrossRef] [PubMed].
  30. Nolan B., Kim R., Duffy A., Sheth K., De M., Miller C., Chari R., Bankey P., Inhibited neutrophil apoptosis: proteasome dependent NF-kappaB translocation is required for TRAF-1 synthesis, Shock 14 (2000) 290-294 [PubMed].
  31. O'Neill A.J., Doyle B.T., Molloy E., Watson C., Phelan D., Greenan M.C., Fitzpatrick J.M., Watson R.W., Gene expression profile of inflammatory neutrophils: alterations in the inhibitors of apoptosis proteins during spontaneous and delayed apoptosis, Shock 21 (2004) 512-518 [CrossRef] [PubMed].
  32. Paape M.J., Bannerman D.D., Zhao X., Lee J.W., The bovine neutrophil: Structure and function in blood and milk, Vet. Res. 34 (2003) 597-627 [CrossRef] [PubMed] [EDP Sciences].
  33. Pahl H.L., Krauss B., Schulze-Osthoff K., Decker T., Traenckner E.B., Vogt M., Myers C., Parks T., Warring P., Muhlbacher A., Czernilofsky A.P., Baeuerle P.A., The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB, J. Exp. Med. 183 (1996) 1829-1840 [CrossRef] [PubMed].
  34. Pericle F., Liu J.H., Diaz J.I., Blanchard D.K., Wei S., Forni G., Djeu J.Y., Interleukin-2 prevention of apoptosis in human neutrophils, Eur. J. Immunol. 24 (1994) 440-444 [PubMed].
  35. Renard P., Ernest I., Houbion A., Art M., Le Calvez H., Raes M., Remacle J., Development of a sensitive multi-well colorimetric assay for active NFkappaB, Nucleic Acids Res. 29 (2001) E21 [CrossRef] [PubMed].
  36. Renshaw S.A., Parmar J.S., Singleton V., Rowe S.J., Dockrell D.H., Dower S.K., Bingle C.D., Chilvers E.R., Whyte M.K., Acceleration of human neutrophil apoptosis by TRAIL, J. Immunol. 170 (2003) 1027-1033 [PubMed].
  37. Rogalinska M., Alterations in cell nuclei during apoptosis, Cell. Mol. Biol. Lett. 7 (2002) 995-1018 [PubMed].
  38. Rothwarf D.M., Karin M., The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus, Sci. STKE 1999 (1999) RE1.
  39. Sandersen C., Bureau F., Turlej R., Fievez L., Dogne S., Kirschvink N., Lekeux P., p65 Homodimer activity in distal airway cells determines lung dysfunction in equine heaves, Vet. Immunol. Immunopathol. 80 (2001) 315-326 [PubMed].
  40. Stehlik C., de Martin R., Binder B.R., Lipp J., Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B, Biochem. Biophys. Res. Commun. 243 (1998) 827-832 [CrossRef] [PubMed].
  41. Van den Berg J.M., Weyer S., Weening J.J., Roos D., Kuijpers T.W., Divergent effects of tumor necrosis factor alpha on apoptosis of human neutrophils, J. Leukoc. Biol. 69 (2001) 467-473 [PubMed].
  42. Van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., Reutelingsperger C.P., Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure, Cytometry 31 (1998) 1-9 [CrossRef] [PubMed].
  43. Ward C., Chilvers E.R., Lawson M.F., Pryde J.G., Fujihara S., Farrow S.N., Haslett C., Rossi A.G., NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro, J. Biol. Chem. 274 (1999) 4309-4318 [CrossRef] [PubMed].
  44. You M., Ku P.T., Hrdlickova R., Bose H.R. Jr., ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein, Mol. Cell. Biol. 17 (1997) 7328-7341 [PubMed].
  45. Zong W.X., Edelstein L.C., Chen C., Bash J., Gelinas C., The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis, Genes Dev. 13 (1999) 382-387 [PubMed].